Coeptis Therapeutics CEO David Mehalick joins The Watchlist to discuss the biopharma company, which focuses on developing cell therapy platforms for cancer patients. The company recently announced merging with SPAC Bull Horn Holdings, which is anticipated to close in the 3Q of 2022.
The Watch List
20 Apr 2022
SHARE
The Watch List
22 Jan 2023
The Watch List
17 Feb 2023
The Watch List
27 Feb 2023
The Watch List
14 Mar 2023
The Watch List
31 Jan 2023
Current show
Mon—Fri at 10:00 am — 11:00 am
Trading 360